- Clever Leaves ( NASDAQ: CLVR ) said on Monday it had exported THC Flower for medical use from its facility in Portugal to Israeli partner InterCure ( NASDAQ: INCR ).
- Clever Leaves will supply InterCure with a high THC strain followed by several other genetics that will arrive, as part of the long-term partnership agreement between the companies.
- The company said it will cultivate Canndoc’s proprietary genetics in its Colombia and Portugal facilities, meeting all regulatory and compliance standards, for distribution across Israel and other countries.
- ( CLVR ) rose 1.6% before the bell.
For further details see:
Clever Leaves exports cannabis to Israel partner Intercure